NeuroOne Medical Technologies Corp (NMTC)
0.8055
+0.06
(+8.41%)
USD |
NASDAQ |
Jun 28, 16:00
0.783
-0.02
(-2.79%)
After-Hours: 20:00
NeuroOne Medical Technologies Research and Development Expense (TTM): 6.428M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 6.428M |
December 31, 2023 | 6.860M |
September 30, 2023 | 6.941M |
June 30, 2023 | 6.600M |
March 31, 2023 | 5.933M |
December 31, 2022 | 5.432M |
September 30, 2022 | 4.929M |
June 30, 2022 | 4.500M |
March 31, 2022 | 4.175M |
December 31, 2021 | 4.051M |
September 30, 2021 | 3.925M |
June 30, 2021 | 3.701M |
March 31, 2021 | 3.248M |
Date | Value |
---|---|
December 31, 2020 | 2.508M |
September 30, 2020 | 2.076M |
June 30, 2020 | 1.752M |
March 31, 2020 | 1.728M |
December 31, 2019 | 1.822M |
September 30, 2019 | 1.529M |
June 30, 2019 | 1.294M |
March 31, 2019 | 0.9761M |
December 31, 2018 | 0.7747M |
June 30, 2018 | 0.8372M |
March 31, 2018 | 0.7683M |
December 31, 2017 | 0.7353M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
1.529M
Minimum
Sep 2019
6.941M
Maximum
Sep 2023
4.112M
Average
4.051M
Median
Dec 2021
Research and Development Expense (TTM) Benchmarks
Align Technology Inc | 351.24M |
SINTX Technologies Inc | 8.516M |
Nutriband Inc | 2.534M |
enVVeno Medical Corp | 13.04M |
Beyond Air Inc | 24.36M |